Market Overview:
The global nephrology and urology devices market size reached US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 6.7 Billion |
Market Forecast in 2032
|
US$ 10.9 Billion |
Market Growth Rate 2024-2032 |
5.4% |
Nephrology and urology devices are medical equipment used for the treatment of kidney and urinary system-related diseases. Some of the commonly used devices include instruments and consumables, such as ureteral and percutaneous nephrostomy (PCN) catheters, urinary stents, vaginal meshes and slings, stone baskets, urology guidewires and renal dilators. These devices are widely used for hemo- and peritoneal dialysis, urinary stone removal, catheter ablation and sacral neuromodulation. They are used for treating any swellings or blockages in the urinary tract and find extensive applications across hospitals, clinics, dialysis centers and research laboratories.

The increasing prevalence of chronic diseases, including chronic kidney diseases (CKD), urinary incontinence, benign prostatic hyperplasia (BPH) and end-stage renal disease (ESRD), across the globe is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to ailments, such as diabetes and prostate cancer, is providing a thrust to the market growth. With the growing consumer awareness regarding the effective treatment alternatives for such disorders, there is an escalating demand for minimally invasive (MI) devices manufactured using advanced biocompatible materials, such as nitinol, polyurethanes, polycarbonates and silicone. These materials provide superior kink resistance, smooth insertion capabilities and facilitate high flow rates with low vein and arterial pressure. Additionally, the widespread utilization of percutaneous methods for stone disintegration and extraction, prosthetics in urology and extracorporeal shockwave lithotripsy for early diagnosis and shorter treatment duration, are contributing to the market growth. Other factors, including rising healthcare expenditures, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global nephrology and urology devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and end use.
Breakup by Product:
- Ureteral Catheters
- PCN Catheters
- Urinary Stents
- Stone Basket
- Urology Guidewires
- Renal Dilators
- Others
Breakup by End Use:
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Boston Scientific Corp., Coloplast A/S, Cook Group Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Nipro Corporation and Nxstage Medical Inc. (Fresenius Medical Care).
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Product, End Use, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Boston Scientific Corp., Coloplast A/S, Cook Group Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Nipro Corporation and Nxstage Medical Inc. (Fresenius Medical Care) |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global nephrology and urology devices market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global nephrology and urology devices market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global nephrology and urology devices market and who are the key players?
- What is the degree of competition in the industry?